Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
AICAR structure

AICAR

Metabolic
Phase 2 Research
40%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 250 mg
Range 150 - 500 mg
Maintenance 250 mg daily or pre-workout

Pharmacokinetics

Half-Life 1.0 hrs
Onset 30 min
Peak 1.5 hrs
Duration 4.0 hrs
Bioavailability 5%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intravenous
Injection Sites Abdomen, Thigh
Needle Gauge 29-31G
Syringe Type Insulin
Timing pre workout, Fasted

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Stability 14 days refrigerated
Vial Sizes 50, 100 mg

Special Instructions

Exercise mimetic - inject 30-60 min before training. Poor oral bioavailability (<5%) requires injection. Does not cross blood-brain barrier efficiently. WADA prohibited.